Effect of Antacid on the Pharmacokinetics of Extended-Release Formulations of Tolterodine and Oxybutynin

ISSN： 0312-5963

Source： Clinical Pharmacokinetics, Vol.43, Iss.14, 2004-01, pp. : 1059-1068

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Cost-Effectiveness Analysis of Extended-Release Formulations of Oxybutynin and Tolterodine for the Management of Urge Incontinence

By Hughes Dyfrig A.

PharmacoEconomics, Vol. 22, Iss. 16, 2004-01 ,pp. : 1047-1059

Adis International

Access to resources Recommend Favorite

Extended-Release Oxybutynin

By Comer A.M. Goa K.L.

Drugs & Aging, Vol. 16, Iss. 2, 2000-02 ,pp. : 149-155

Adis International

Access to resources Recommend Favorite

Oxybutynin Extended Release and Tolterodine Immediate Release: A Health Economic Comparison

By Getsios D.

Clinical Drug Investigation, Vol. 24, Iss. 2, 2004-01 ,pp. : 81-88

Adis International

Access to resources Recommend Favorite

Comparison of the pharmacokinetics and clinical efficacy of new extended-release formulations of methylphenidate

By Maldonado Rafael

Expert Opinion on Drug Metabolism and Toxicology, Vol. 9, Iss. 8, 2013-08 ,pp. : 1001-1014

Informa Healthcare

Access to resources Recommend Favorite

Extended-release oxybutynin an effective option in overactive bladder

Inpharma, Vol. 1, Iss. 1303, 2001-01 ,pp. : 13-14

Adis International

Access to resources Recommend Favorite